Nanjing Pharmaceutical Company Limited’s Net Profit Rose 20.9% in First Quarter of 2023

Nanjing Pharmaceutical Company Limited (南京医药股份有限公司) (600713.SH) reported a net profit of 183.6 million yuan in the first quarter of 2023, up 20.9% year-on-year.

Meanwhile, the company posted 14.1 billion yuan in revenue, up 20.4% year-on-year.

At the end of the reporting period, it had 32.9 billion yuan in total assets and 26 billion yuan in total liabilities, with a liability-to-asset ratio of 79%.